Search Videos by Topic or Participant
Browse by Series:

Anemia and Iron Overload: Prevalence in Patients With MDS

Panelists: Azra Raza, MD.
Published: Wednesday, Jan 14, 2015
For High-Definition, Click
Azra Raza, MD, discusses that up to 85% of patients with myelodysplastic syndrome (MDS) will also experience anemia. These patients will present with low hemoglobin levels and, depending on their subtype of MDS, up to one-half will require transfusions.

The possibility of iron overload becomes a concern when these patients require multiple transfusions, exceeding a total 20 units of red blood cells, and their serum ferritin is >1000 ng/ml. Raza states that in her practice, at least one-third of the patients with lower-risk MDS who are receiving chronic transfusions will be at risk of iron overload.
Slider Left
Slider Right
For High-Definition, Click
Azra Raza, MD, discusses that up to 85% of patients with myelodysplastic syndrome (MDS) will also experience anemia. These patients will present with low hemoglobin levels and, depending on their subtype of MDS, up to one-half will require transfusions.

The possibility of iron overload becomes a concern when these patients require multiple transfusions, exceeding a total 20 units of red blood cells, and their serum ferritin is >1000 ng/ml. Raza states that in her practice, at least one-third of the patients with lower-risk MDS who are receiving chronic transfusions will be at risk of iron overload.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and VomitingOct 31, 20182.0
Publication Bottom Border
Border Publication
x